Diseases & Disorders
(G54Z)
IRS Verified
DX Registered
990 on File
EPILEPSY FOUNDATION OF DELAWARE
Financial strength (30%)
90/100
Reliability (20%)
55/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$249K
Total Revenue
$239K
Total Expenses
$423K
Net Assets
4
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
79.8%
Fundraising Efficiency
28.5%
Operating Reserve
21.21x
Liability-to-Asset
13.6%
Revenue Diversification
58.7%
Executive Compensation
$73K
Compared with Peers
FY 2025
Compared with 693 similar organizations
(United States, Diseases & Disorders, $100K–$1M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
79.8% | 83.5% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
8.0% | 10.0% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
12.2% | 0.0% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
28.5% | 15.8% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
21.2 mo | 11.9 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
13.6% | 0.6% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
58.7% | 93.4% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
2.0% | 7.5% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
6.3% | 8.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
4.0% | 4.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $249K | $239K | $423K | 79.8% | 4 |
| 2024 | $244K | $225K | $406K | 80.0% | 4 |
| 2023 | $215K | $201K | $378K | 79.0% | 5 |
| 2022 | $187K | $174K | $362K | 78.7% | 5 |
| 2021 | $180K | $168K | N/A | — | 5 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.